Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Human vascular progenitor cells used to treat diabetes ulcers

14.12.2006
EVGN scientists identified blood vessels cells that succeed in repairing ulcers caused by diabetes mellitus.

Every 30 minutes a diabetic patient loses the use of his bottom limb due to the ulceration of tissues that degenerates into a necrosis, which is a typical side effect of this disease. For this reason, finding a proper treatment able to arrest this complication is among the priorities of the scientists who study this pathology.

Paolo Madeddu, scientist of the European Vascular Genomics Network (EVGN, www.evgn.org) from the University of Bristol, in a collaborative effort with colleagues from the Istituto Besta in Milano and EVGN scientists from INSERM U441 in Bordeaux, devised an experimental model based on the administration of Vascular Progenitor Cells (VPC). In the laboratory settings the model proved to be effective on ischemic diabetic ulcers.

The research was presented today, December 13th 2006, at the Annual EVGN Conference which is taking place in Toulouse (Dec. 11-14). As they are still preliminary data, the applications of these results to man are still far in the future. However, these extremely encouraging results prompted the scientist to start a whole set of new experiments aimed at the characterization of the compounds secreted by the VPCs, which are responsible for the healing properties on diabetic ulcers.

... more about:
»EVGN »Madeddu »VPC »ulcers »vascular cells

Diabetes is a social disease that affects several million people worldwide. The ischemic ulcers it causes are lesions that damage the deepest layers of tissues, markedly reducing muscles and bones functions. Quite often, they generate infections that aggravate the conditions of already compromised patients. It’s been a few years since scientists developed an interest in the therapeutic potential of stem cells for the treatment of diabetic ulcers. In this study, however, Paolo Madeddu and colleagues used so-called Vascular Progenitor Cells. “These cells have not been fully characterized yet” explained the EVGN scientist “but we know that they display a considerable regenerative potential in the vascular environment. Besides, they are able to counteract the cellular suicide, or apoptosis”.

A major objective of the study was the creation of a diabetic model that allowed the scientists to test the regenerative capacities of VPCs. “We employed a murine model that can develop ulcers similar to those observed in humans” Madeddu said. “Then we administered a specific subpopulation of VPCs and, a week after the treatment, we checked what was the overall effect on the ulcers. We observed that the treated lesions had become thinner and smaller compared to the untreated ones, and that they were surrounded by a number of newborn capillaries, indicating that a regeneration process was ongoing”.

A further confirmation that the treatment was efficacious came from another observation: scientists noticed that VPCs stimulated cellular proliferation and inhibited cellular apoptosis, a defensive mechanism which is active also in necrotic tissues that the organism resorts to when it is unable to heal damages. Effective as well was the “conditioned medium”, that is the medium where cells were cultured, after its administration on the lesions. “The medium – underlined Madeddu – contains one or more unidentified factors that stimulate endothelial cell proliferation. Its identification will be critical for the future of this research. These and other future results could set the ground for a targeted therapy, based on the administration of progenitor cells, or in alternative, on the administration of the therapeutic compounds that they secrete.

The European Vascular Genomics Network (EVGN) is the first Network of Excellence on cardiovascular disease funded by the European Commission under the 6th Framework Programme "Life sciences, genomics and biotechnology for health" (Contract Number: LSHM-CT-2003-503254).

The Conference is supported by an unrestricted educational grant from Laboratoires SERVIER.

Francesca Noceti | alfa
Further information:
http://www.evgn.org
http://www.ifom-ieo-campus.it

Further reports about: EVGN Madeddu VPC ulcers vascular cells

More articles from Life Sciences:

nachricht Scientists unlock ability to generate new sensory hair cells
22.02.2017 | Brigham and Women's Hospital

nachricht New insights into the information processing of motor neurons
22.02.2017 | Max Planck Florida Institute for Neuroscience

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Microhotplates for a smart gas sensor

22.02.2017 | Power and Electrical Engineering

Scientists unlock ability to generate new sensory hair cells

22.02.2017 | Life Sciences

Prediction: More gas-giants will be found orbiting Sun-like stars

22.02.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>